Cardlytics Inc (CDLX)
7.92
-0.16
(-1.98%)
USD |
NASDAQ |
Jul 02, 12:28
Cardlytics Research and Development Expense (Annual): 51.35M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 51.35M |
| December 31, 2022 | 54.44M |
| December 31, 2021 | 38.10M |
| December 31, 2020 | 17.53M |
| December 31, 2019 | 11.70M |
| Date | Value |
|---|---|
| December 31, 2018 | 16.21M |
| December 31, 2017 | 12.15M |
| December 31, 2016 | 13.90M |
| December 31, 2015 | 11.60M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
11.70M
Minimum
2019
54.44M
Maximum
2022
34.62M
Average
38.10M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Stagwell Inc | -- |
| Lendway Inc | -- |
| Ziff Davis Inc | 68.86M |
| Travelzoo | 2.113M |
| Dolphin Entertainment Inc | -- |